Ten Years’ Experience with the CYP2D6 Activity Score: A Perspective on Future Investigations to Improve Clinical Predictions for Precision Therapeutics
The seminal paper on the CYP2D6 Activity Score (AS) was first published ten years ago and, since its introduction in 2008, it has been widely accepted in the field of pharmacogenetics. This scoring system facilitates the translation of highly complex CYP2D6 diplotype data into a patient’s...
Main Authors: | Andrea Gaedigk, Jean C. Dinh, Hyunyoung Jeong, Bhagwat Prasad, J. Steven Leeder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-04-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2075-4426/8/2/15 |
Similar Items
-
Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan
by: Jan Grzegorzewski, et al.
Published: (2022-10-01) -
Identification of novel CYP2D7-2D6 hybrids: non-functional and functional variants
by: Andrea Gaedigk, et al.
Published: (2010-10-01) -
Effect of 30 mg Oral Dextromethorphan and Placebo on Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy
by: Mahmoud Rezaei, et al.
Published: (2023-06-01) -
Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms
by: Seung-Hyun Jeong, et al.
Published: (2022-04-01) -
The effect of acute administration of quinidine, dextromethorphan and combination of dextromethorphan/quinidine on pentylenetetrazole-induced clonic and tonic seizure thresholds in mice
by: Hassan Jamali, et al.
Published: (2019-08-01)